Amgen Aktie News

Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price. Analyst forecasts suggest top-ten Dow Dogs could deliver average net gains of 20% by October 2026, with VZ among the safer high-yield picks. Most Dow Dogs remain overpriced relative to their dividends, but market pullbacks could create fair-value opportunities for ...

Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (AMGN 0.19%) started the year strong, but has not maintained that momentum.

The Dogs of the Dow is a well-known strategy first published in 1991 by Michael O'Higgins.

Adding Repatha to Standard Therapy of Statins or Other LDL-C Lowering Treatments Significantly Reduces Cardiovascular Events Compared with Standard Therapy Alone Repatha is Now the First and Only PCSK9 Inhibitor to Demonstrate Significant Reduction of Cardiovascular Events as Both Primary and Secondary Prevention THOUSAND OAKS, Calif. , Oct. 2, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today ann...

There are a million and one ways to put your money to work on Wall Street. It might surprise you to learn that investing in dividend growth stocks isn't just one of the easiest; it's also one of the most effective.

In trading on Wednesday, shares of Amgen crossed above their 200 day moving average of $287.75, changing hands as high as $296.76 per share. Amgen shares are currently trading up about 5% on the day.

President Donald Trump delivered the pharmaceutical industry another blow this week, threatening 100% tariffs on some companies.

Investors love dividend stocks because they offer a significant income stream and have massive total return potential.